Position in XERS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,688,910
-$670,508 QoQ
Shares Held
339,509
-41.4% QoQ
Ownership
0.186%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 238 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SEI INVESTMENTS CO holds $374,044,345 across 37 Drug Manufacturers - Specialty & Generic names. XERS ranks #19 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
5,284,773 | $130,058,261 | |
| 2 | VTRS |
Viatris Inc
|
3,165,469 | $50,267,647 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,105,005 | $37,437,568 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
185,545 | $31,271,754 | |
| 5 | ZTS |
Zoetis Inc.
|
237,394 | $17,059,132 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
188,565 | $12,058,731 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
690,897 | $11,959,425 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
98,305 | $10,905,956 |
All Filings in XERS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,688,910 | 339,509 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,359,418 | 579,210 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,134,873 | 399,347 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $986,372 | 121,176 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $544,211 | 116,534 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $535,224 | 97,491 | Shares | Defined | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||